# Evaluation of Safety and Efficacy of DM-28 for Treatment of Moderate to Severe Ocular Dryness

> **NCT06607237** · NA · COMPLETED · sponsor: **Horus Pharma** · enrollment: 44 (actual)

## Conditions studied

- Dry Eye

## Interventions

- **DEVICE:** DM-28

## Key facts

- **NCT ID:** NCT06607237
- **Lead sponsor:** Horus Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-09-26
- **Primary completion:** 2025-01-09
- **Final completion:** 2025-01-09
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2025-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06607237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06607237, "Evaluation of Safety and Efficacy of DM-28 for Treatment of Moderate to Severe Ocular Dryness". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06607237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*